Tags

Type your tag names separated by a space and hit enter

Variant Creutzfeldt-Jakob disease.
Lancet. 1999 Jul 24; 354(9175):317-23.Lct

Abstract

It is clear that the prion strain causing bovine spongiform encephalopathy (BSE) in cattle has infected human beings, manifesting itself as a novel human prion disease, variant Creutzfeldt-Jakob disease (CjD). Studies of the incubation periods seen in previous epidemics of human prion disease and of the effect of transmission barriers limiting spread of these diseases between species, suggest that the early variant CJD cases may have been exposed during the preclinical phase of the BSE epidemic. It must therefore be considered that many cases may follow from later exposure in an epidemic that would be expected to evolve over decades. Since the number of people currently incubating this disease is unknown, there are concerns that prions might be transmitted iatrogenically via blood transfusion, tissue donation, and, since prions resist routine sterilisation, contamination of surgical instruments. Such risks remain unquantified. Although variant CJD can be diagnosed during life by tonsil biopsy, a prion-specific blood test is needed to assess and manage this potential threat to public health. The theoretical possibility that BSE prions might have transferred to other species and continue to present a risk to human health cannot be excluded at present.

Authors+Show Affiliations

Department of Neurogenetics, Imperial College School of Medicine at St Mary's, London, UK. J.Collinge@ic.ac.uk

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

10440324

Citation

Collinge, J. "Variant Creutzfeldt-Jakob Disease." Lancet (London, England), vol. 354, no. 9175, 1999, pp. 317-23.
Collinge J. Variant Creutzfeldt-Jakob disease. Lancet. 1999;354(9175):317-23.
Collinge, J. (1999). Variant Creutzfeldt-Jakob disease. Lancet (London, England), 354(9175), 317-23.
Collinge J. Variant Creutzfeldt-Jakob Disease. Lancet. 1999 Jul 24;354(9175):317-23. PubMed PMID: 10440324.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Variant Creutzfeldt-Jakob disease. A1 - Collinge,J, PY - 1999/8/10/pubmed PY - 2000/2/19/medline PY - 1999/8/10/entrez SP - 317 EP - 23 JF - Lancet (London, England) JO - Lancet VL - 354 IS - 9175 N2 - It is clear that the prion strain causing bovine spongiform encephalopathy (BSE) in cattle has infected human beings, manifesting itself as a novel human prion disease, variant Creutzfeldt-Jakob disease (CjD). Studies of the incubation periods seen in previous epidemics of human prion disease and of the effect of transmission barriers limiting spread of these diseases between species, suggest that the early variant CJD cases may have been exposed during the preclinical phase of the BSE epidemic. It must therefore be considered that many cases may follow from later exposure in an epidemic that would be expected to evolve over decades. Since the number of people currently incubating this disease is unknown, there are concerns that prions might be transmitted iatrogenically via blood transfusion, tissue donation, and, since prions resist routine sterilisation, contamination of surgical instruments. Such risks remain unquantified. Although variant CJD can be diagnosed during life by tonsil biopsy, a prion-specific blood test is needed to assess and manage this potential threat to public health. The theoretical possibility that BSE prions might have transferred to other species and continue to present a risk to human health cannot be excluded at present. SN - 0140-6736 UR - https://www.unboundmedicine.com/medline/citation/10440324/full_citation DB - PRIME DP - Unbound Medicine ER -